211 related articles for article (PubMed ID: 20943696)
1. Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.
White MT; Griffin JT; Riley EM; Drakeley CJ; Moorman AM; Sumba PO; Kazura JW; Ghani AC; John CC
Proc Biol Sci; 2011 May; 278(1710):1298-305. PubMed ID: 20943696
[TBL] [Abstract][Full Text] [Related]
2. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
[TBL] [Abstract][Full Text] [Related]
3. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
Bettencourt P
Front Immunol; 2020; 11():190. PubMed ID: 32153565
[No Abstract] [Full Text] [Related]
4. Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.
John CC; Tande AJ; Moormann AM; Sumba PO; Lanar DE; Min XM; Kazura JW
J Infect Dis; 2008 Feb; 197(4):519-26. PubMed ID: 18275273
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.
White MT; Verity R; Griffin JT; Asante KP; Owusu-Agyei S; Greenwood B; Drakeley C; Gesase S; Lusingu J; Ansong D; Adjei S; Agbenyega T; Ogutu B; Otieno L; Otieno W; Agnandji ST; Lell B; Kremsner P; Hoffman I; Martinson F; Kamthunzu P; Tinto H; Valea I; Sorgho H; Oneko M; Otieno K; Hamel MJ; Salim N; Mtoro A; Abdulla S; Aide P; Sacarlal J; Aponte JJ; Njuguna P; Marsh K; Bejon P; Riley EM; Ghani AC
Lancet Infect Dis; 2015 Dec; 15(12):1450-8. PubMed ID: 26342424
[TBL] [Abstract][Full Text] [Related]
6. Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.
Tewari K; Flynn BJ; Boscardin SB; Kastenmueller K; Salazar AM; Anderson CA; Soundarapandian V; Ahumada A; Keler T; Hoffman SL; Nussenzweig MC; Steinman RM; Seder RA
Vaccine; 2010 Oct; 28(45):7256-66. PubMed ID: 20846528
[TBL] [Abstract][Full Text] [Related]
7. Liver-Directed AAV8 Booster Vaccine Expressing
Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
Front Immunol; 2021; 12():612910. PubMed ID: 34248928
[TBL] [Abstract][Full Text] [Related]
8. Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis.
Felgner PL; Roestenberg M; Liang L; Hung C; Jain A; Pablo J; Nakajima-Sasaki R; Molina D; Teelen K; Hermsen CC; Sauerwein R
Sci Rep; 2013 Dec; 3():3549. PubMed ID: 24351974
[TBL] [Abstract][Full Text] [Related]
9. Malaria vaccines and human immune responses.
Long CA; Zavala F
Curr Opin Microbiol; 2016 Aug; 32():96-102. PubMed ID: 27262417
[TBL] [Abstract][Full Text] [Related]
10. Tailoring a Combination Preerythrocytic Malaria Vaccine.
Bauza K; Atcheson E; Malinauskas T; Blagborough AM; Reyes-Sandoval A
Infect Immun; 2015 Dec; 84(3):622-34. PubMed ID: 26667840
[TBL] [Abstract][Full Text] [Related]
11. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
[TBL] [Abstract][Full Text] [Related]
12. Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.
Clement F; Dewar V; Van Braeckel E; Desombere I; Dewerchin M; Swysen C; Demoitié MA; Jongert E; Cohen J; Leroux-Roels G; Cambron P
Malar J; 2012 Nov; 11():384. PubMed ID: 23173602
[TBL] [Abstract][Full Text] [Related]
13. The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.
White MT; Bejon P; Olotu A; Griffin JT; Riley EM; Kester KE; Ockenhouse CF; Ghani AC
PLoS One; 2013; 8(4):e61395. PubMed ID: 23613845
[TBL] [Abstract][Full Text] [Related]
14. Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults.
Kester KE; Gray Heppner D; Moris P; Ofori-Anyinam O; Krzych U; Tornieporth N; McKinney D; Delchambre M; Ockenhouse CF; Voss G; Holland C; Beckey JP; Ballou WR; Cohen J;
Vaccine; 2014 Nov; 32(49):6683-91. PubMed ID: 24950358
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.
Aguiar JC; Bolton J; Wanga J; Sacci JB; Iriko H; Mazeika JK; Han ET; Limbach K; Patterson NB; Sedegah M; Cruz AM; Tsuboi T; Hoffman SL; Carucci D; Hollingdale MR; Villasante ED; Richie TL
PLoS One; 2015; 10(8):e0136109. PubMed ID: 26292257
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
Speake C; Pichugin A; Sahu T; Malkov V; Morrison R; Pei Y; Juompan L; Milman N; Zarling S; Anderson C; Wong-Madden S; Wendler J; Ishizuka A; MacMillen ZW; Garcia V; Kappe SH; Krzych U; Duffy PE
PLoS One; 2016; 11(7):e0159449. PubMed ID: 27434123
[TBL] [Abstract][Full Text] [Related]
17. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.
Trieu A; Kayala MA; Burk C; Molina DM; Freilich DA; Richie TL; Baldi P; Felgner PL; Doolan DL
Mol Cell Proteomics; 2011 Sep; 10(9):M111.007948. PubMed ID: 21628511
[TBL] [Abstract][Full Text] [Related]
18. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.
Noland GS; Jansen P; Vulule JM; Park GS; Ondigo BN; Kazura JW; Moormann AM; John CC
Acta Trop; 2015 Feb; 142():47-56. PubMed ID: 25446174
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.
Foquet L; Hermsen CC; van Gemert GJ; Van Braeckel E; Weening KE; Sauerwein R; Meuleman P; Leroux-Roels G
J Clin Invest; 2014 Jan; 124(1):140-4. PubMed ID: 24292709
[TBL] [Abstract][Full Text] [Related]
20. Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.
Vom Steeg LG; Flores-Garcia Y; Zavala F; Klein SL
Vaccine; 2019 Jul; 37(32):4468-4476. PubMed ID: 31262583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
